1) insulin aspart 30/70
预混门冬氨酸胰岛素30/70
1.
Objective To investigate the efficacy and safety of insulin aspart 30/70 in the treatment of type 2 diabetes mellitus(T2DM).
目的观察预混门冬氨酸胰岛素30/70(降血糖药)对2型糖尿病的疗效与安全性。
2) BIAsp 70/30
双相门冬胰岛素70/30
3) insulin aspart 30
门冬胰岛素30
1.
Localized lipoatrophy induced by insulin aspart 30;
门冬胰岛素30致局限性脂肪萎缩
2.
Effects of insulin aspart 30 injection in treatment of type 2 diabetes
门冬胰岛素30治疗初诊2型糖尿病疗效观察
3.
Effects of insulin aspart 30 and acarbose on β-cell function in newly diagnosed type 2 diabetes
门冬胰岛素30联合阿卡波糖对初诊2型糖尿病胰岛功能的影响
4) Insulin Aspart 30 Injection
门冬胰岛素30注射液
1.
Curative effect of combination therapy of Insulin Aspart 30 Injection and Tongxinluo Capsule on diabetes peripheral neuropathy
门冬胰岛素30注射液联合通心络胶囊治疗糖尿病周围神经病变60例
5) Insulin aspart
门冬胰岛素
1.
Efficacy and safety of insulin aspart used in continuous subcutaneous insulin infusion therapy in children and adolescences with type 1 diabetes;
门冬胰岛素在青少年1型糖尿病胰岛素泵中的应用
2.
Studies on effects of insulin aspart and human regular insulin on blood glucose in elderly type 2 diabetic patients with irregular food intake;
门冬胰岛素与人正规胰岛素对不规律进食老年2型糖尿病患者血糖影响的研究
3.
Intensive diabetic treatment and administration of insulin aspart in children and adolescents
儿童青少年糖尿病强化治疗及门冬胰岛素的应用
6) premixed insulin
预混胰岛素
1.
Objectives:To compare the once-daily basal insulin(insulin glargine) plus 1 or 2 OAD versus twice-daily premixed insulin(70/30) plus 1 or 2 OAD as therapy for Type 2 diabetes mellitus on efficacy and safety of clinical study.
目的:对一天一次基础胰岛素(甘精胰岛素)联合1或2种OAD (Oral Anti-diabetic Drug,OAD)与一天两次预混胰岛素(70/30)联合1或2种OAD在治疗2型糖尿病(Type 2 diabetes mellitus,T2DM)的疗效与安全性方面进行临床比较。
2.
Methods:Sixty cases which were in accordance with the inclusion criteria of type 2 diabetes of preliminary diagnosis were randomly divided into group A(insulin glargine and metformin tablets or acarbose) and group B(premixed insulin).
方法:将符合纳入标准的60例初诊2型糖尿病患者随机分为A组(甘精胰岛素联合口服二甲双胍片或阿卡波糖片组)30例,B组(预混胰岛素组)30例。
补充资料：素门
1.寒素门第。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条